TRAM Snapshot of App at Pub for Oppostn

COSENTYX

Novartis AG

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 86734365 FILING DATE 08/24/2015
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY HOWARD, PARKER WALDRIP
L.O. ASSIGNED 117

PUB INFORMATION

RUN DATE 05/12/2016
PUB DATE 11/24/2015
STATUS 819-SU - REGISTRATION REVIEW COMPLETE
STATUS DATE 05/11/2016
LITERAL MARK ELEMENT COSENTYX

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) YES 1 (a) NO
1 (b) YES 1 (b) NO 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT COSENTYX
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Novartis AG
ADDRESS CH-4002
Basel, 
ENTITY 03-CORPORATION
CITIZENSHIP Switzerland

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Anti-inflammatories; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for use in rheumatology

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE 01/15/2016 FIRST USE IN COMMERCE DATE 01/15/2016 CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
OWNER OF US REG NOS 4427248    4716891   

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
05/12/2016 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED 016
05/11/2016 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED 015
04/28/2016 SUPC I STATEMENT OF USE PROCESSING COMPLETE 014
03/22/2016 IUAF S USE AMENDMENT FILED 013
04/25/2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL 012
03/22/2016 EISU I TEAS STATEMENT OF USE RECEIVED 011
03/22/2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 010
02/08/2016 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED 009
12/22/2015 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED 008
11/24/2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 007
11/24/2015 PUBO A PUBLISHED FOR OPPOSITION 006
11/04/2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 005
10/20/2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 004
10/19/2015 DOCK D ASSIGNED TO EXAMINER 003
08/27/2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
08/27/2015 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Maury M. Tepper, III
CORRESPONDENCE ADDRESS MAURY M. TEPPER, III
Tepper & Eyster Pllc
3724 Benson Dr
Raleigh, NC 27609-7321
DOMESTIC REPRESENTATIVE Novartis Pharmaceuticals Corporation

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Novartis AG
ADDRESS CH-4002
Basel, 
ENTITY 03-CORPORATION
CITIZENSHIP Switzerland

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed